Ca2+-Activated K+Channel–3.1 Blocker TRAM-34 Attenuates Airway Remodeling and Eosinophilia in a Murine Asthma Model
出版年份 2012 全文链接
标题
Ca2+-Activated K+Channel–3.1 Blocker TRAM-34 Attenuates Airway Remodeling and Eosinophilia in a Murine Asthma Model
作者
关键词
-
出版物
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Volume 48, Issue 2, Pages 212-219
出版商
American Thoracic Society
发表日期
2012-11-30
DOI
10.1165/rcmb.2012-0103oc
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mast Cells Promote Airway Smooth Muscle Cell Differentiation via Autocrine Up-Regulation of TGF- 1
- (2014) L. Woodman et al. JOURNAL OF IMMUNOLOGY
- Blunted IgE-Mediated Activation of Mast Cells in Mice Lacking the Ca2+-Activated K+ Channel KCa3.1
- (2014) E. Shumilina et al. JOURNAL OF IMMUNOLOGY
- Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the gardos channel blocker senicapo
- (2011) Kenneth I. Ataga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Functional KCa3.1 K+ channels are required for human fibrocyte migration
- (2011) Glenn Cruse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion Stroke
- (2011) Yi-Je Chen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Airway remodeling in asthma: New mechanisms and potential for pharmacological intervention
- (2011) Pierre-Olivier Girodet et al. PHARMACOLOGY & THERAPEUTICS
- Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6
- (2010) P.-O. Girodet et al. ALLERGY
- T Cells Localize with Proliferating Smooth Muscle α-Actin+Cell Compartments in Asthma
- (2010) David Ramos-Barbón et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pathophysiology of bronchial smooth muscle remodelling in asthma
- (2010) I. Bara et al. EUROPEAN RESPIRATORY JOURNAL
- CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung
- (2010) Cyrille Mionnet et al. NATURE MEDICINE
- The K+channels KCa3.1 and Kv1.3 as novel targets for asthma therapy
- (2009) Peter Bradding et al. BRITISH JOURNAL OF PHARMACOLOGY
- Airway remodeling in a mouse asthma model assessed by in-vivo respiratory-gated micro-computed tomography
- (2009) Mathieu Lederlin et al. EUROPEAN RADIOLOGY
- Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction
- (2009) Marta Kaminska et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels
- (2009) I. Grgic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma
- (2009) K. Mahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction
- (2008) Jill R. Johnson et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
- (2008) K. I. Ataga et al. BLOOD
- Airway hyperresponsiveness is dissociated from airway wall structural remodeling
- (2008) Salman Siddiqui et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans
- (2008) Kazuyoshi Toyama et al. JOURNAL OF CLINICAL INVESTIGATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started